Colgate-Palmolive (NYSE:CL) Price Target Lowered to $95.00 at Raymond James Financial

Key Points

• Colgate-Palmolive saw its price target lowered by Raymond James Financial from $105.00 to $95.00 while maintaining an "outperform" rating, indicating a potential upside of 20.06% from the last close.
• Other analysts have also decreased their price targets, with Morgan Stanley setting it at $96.00 and JPMorgan at $88.00, reflecting overall bearish sentiment in recent reports.
• Despite the target cuts, Colgate-Palmolive has delivered earnings of $0.92 per share, surpassing estimates, and reported an annual revenue growth of 1.0% in its latest quarterly results.

Colgate-Palmolive (NYSE:CL - Get Free Report) had its target price lowered by stock analysts at Raymond James Financial from $105.00 to $95.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Raymond James Financial's price target would indicate a potential upside of 20.06% from the company's previous close.

Several other research analysts have also issued reports on CL. Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $83.00 to $80.00 and set an "underweight" rating for the company in a report on Thursday, September 25th. JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $95.00 to $88.00 and set an "overweight" rating for the company in a report on Friday, October 10th. Barclays lowered their price target on shares of Colgate-Palmolive from $87.00 to $82.00 and set an "equal weight" rating for the company in a report on Wednesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft set a $86.00 price target on shares of Colgate-Palmolive in a report on Friday, October 10th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Colgate-Palmolive has an average rating of "Moderate Buy" and a consensus price target of $91.50.

Colgate-Palmolive Trading Up 0.0%

NYSE CL traded up $0.01 during trading hours on Monday, reaching $79.13. The company's stock had a trading volume of 1,633,305 shares, compared to its average volume of 5,293,043. The firm has a fifty day simple moving average of $81.96 and a 200-day simple moving average of $87.28. The stock has a market cap of $63.95 billion, a P/E ratio of 22.22, a P/E/G ratio of 4.64 and a beta of 0.34. Colgate-Palmolive has a 52 week low of $76.68 and a 52 week high of $100.49. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm's quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the business earned $0.91 EPS. Equities analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Institutional Trading of Colgate-Palmolive

Large investors have recently modified their holdings of the stock. Brighton Jones LLC grew its position in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after purchasing an additional 450 shares during the period. GAMMA Investing LLC grew its position in Colgate-Palmolive by 14.2% in the 1st quarter. GAMMA Investing LLC now owns 11,797 shares of the company's stock valued at $1,105,000 after purchasing an additional 1,468 shares during the period. Advisor Resource Council acquired a new stake in Colgate-Palmolive in the 1st quarter valued at $313,000. Manning & Napier Advisors LLC grew its position in Colgate-Palmolive by 88.3% in the 1st quarter. Manning & Napier Advisors LLC now owns 68,205 shares of the company's stock valued at $6,391,000 after purchasing an additional 31,979 shares during the period. Finally, TrueMark Investments LLC grew its position in Colgate-Palmolive by 264.7% in the 1st quarter. TrueMark Investments LLC now owns 16,737 shares of the company's stock valued at $1,568,000 after purchasing an additional 12,148 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.